Ophthalmology – Vitamin A Deficiency/Xerophthalmia

What the Disorder Represents

Xerophthalmia is the spectrum of ocular disease caused by vitamin A deficiency (VAD).

It progresses from functional retinal dysfunction to destructive ocular-surface disease:

Night blindness → conjunctival xerosis → Bitot spots → corneal xerosis → corneal ulceration/keratomalacia → permanent corneal scarring or blindness

Vitamin A deficiency is also a systemic nutritional disorder associated with:

• Impaired immunity
• Increased susceptibility to infection
• Poor growth in children
• Increased childhood morbidity and mortality

Where the Disease Is Most Important

Clinical xerophthalmia is uncommon in well-nourished populations but remains an important public-health problem in areas with:

• Food insecurity
• Malnutrition
• Limited dietary diversity
• High childhood infection burden
• Poor access to healthcare

The greatest burden occurs particularly in parts of:

• Sub-Saharan Africa
• South and Southeast Asia

Young children are especially vulnerable.

Who Is at Greatest Risk

Important risk groups include:

• Preschool children
• Severe protein-energy malnutrition
• Food insecurity
• Restricted diets
• Chronic diarrhea
• Malabsorption
• Chronic liver or pancreatic disease
• Bariatric or gastrointestinal surgery
• Cystic fibrosis
• Cholestatic disorders
• Inflammatory bowel disease
• Severe eating disorders

Pregnancy and lactation increase vitamin A requirements, although high-dose supplementation requires particular caution.

Why Measles Matters

Vitamin A deficiency and measles have a particularly dangerous relationship.

Children with measles may develop:

• Rapid depletion of vitamin A stores
• Severe xerophthalmia
• Corneal ulceration
• Keratomalacia

Vitamin A supplementation is therefore routinely recommended for children with measles according to age-based public-health guidelines.

How Vitamin A Supports Vision

Vitamin A has two major ocular functions.

In the Retina

Vitamin A is required to generate:

11-cis-retinal

which combines with opsin to form visual pigments such as:

Rhodopsin

in rod photoreceptors.

Deficiency therefore first impairs:

Dark adaptation and night vision.

On the Ocular Surface

Vitamin A maintains normal differentiation of:

• Conjunctival epithelium
• Corneal epithelium
• Goblet cells

Deficiency causes:

Loss of goblet cells + squamous metaplasia + keratinization → severe ocular-surface dryness.

Why Protein and Zinc Status Matter

Vitamin A circulates bound to:

Retinol-binding protein (RBP).

Adequate protein and zinc are needed for normal:

• RBP synthesis
• Retinol transport
• Vitamin A metabolism

Severe malnutrition can therefore impair vitamin A delivery even when some hepatic stores remain.

Sources of Vitamin A

Vitamin A is obtained as:

Preformed Vitamin A

From animal foods such as:

• Liver
• Eggs
• Dairy products
• Fish

Provitamin A Carotenoids

From plant foods such as:

• Carrots
• Sweet potatoes
• Pumpkin
• Dark green leafy vegetables
• Orange/yellow fruits

Plant carotenoids require intestinal conversion to retinol and are generally:

Less bioavailable than preformed vitamin A.

The Earliest Ocular Symptom

The classic earliest symptom is:

Night blindness (nyctalopia).

Patients may report:

• Difficulty seeing after sunset
• Slow dark adaptation
• Trouble navigating dim rooms

Children may become reluctant to move around after dark.

Why Night Blindness Comes First

Rod photoreceptors depend heavily on rhodopsin regeneration.

Vitamin A depletion therefore affects:

Scotopic vision before central daylight acuity.

Night blindness can improve rapidly after vitamin A replacement.

WHO Xerophthalmia Classification

The classic WHO clinical grading system includes:

• XN – night blindness
• X1A – conjunctival xerosis
• X1B – Bitot spots
• X2 – corneal xerosis
• X3A – corneal ulceration/keratomalacia involving <1/3 of cornea
• X3B – corneal ulceration/keratomalacia involving ≥1/3 of cornea
• XS – corneal scar from xerophthalmia
• XF – xerophthalmic fundus

This remains useful for recognizing disease severity.

Conjunctival Xerosis

The conjunctiva loses its normal:

• Smoothness
• Luster
• Moist appearance

and becomes:

• Dry
• Dull
• Wrinkled
• Keratinized

Changes are often most apparent on the:

Temporal bulbar conjunctiva.

Bitot Spots

Bitot spots are characteristic superficial conjunctival lesions composed of keratinized epithelium and debris.

They typically appear as:

• White or gray
• Foamy
• Triangular or irregular plaques

most commonly on the:

Temporal bulbar conjunctiva near the limbus.

Why Bitot Spots Look Foamy

The characteristic frothy appearance results from:

• Keratinized epithelial debris
• Lipid
• Colonization by surface organisms

They strongly suggest xerophthalmia in the appropriate nutritional context.

Corneal Xerosis

More advanced deficiency causes the cornea to become:

• Dry
• Hazy
• Irregular
• Poorly wettable

The normal smooth epithelial surface is lost.

This stage can progress rapidly to:

Corneal ulceration and melting.

Keratomalacia

Keratomalacia is liquefactive corneal necrosis caused by severe vitamin A deficiency.

It may lead to:

• Stromal melting
• Descemetocele
• Perforation
• Endophthalmitis
• Loss of the eye

Keratomalacia is an:

Ophthalmic and systemic nutritional emergency.

Why Keratomalacia Can Progress So Rapidly

Severe VAD produces:

• Profound epithelial breakdown
• Loss of ocular-surface barrier function
• Stromal degradation
• Increased susceptibility to secondary infection

Corneal destruction may progress over:

Hours to days.

Xerophthalmic Fundus

Rarely, vitamin A deficiency causes a retinal appearance known as:

Xerophthalmic fundus

with multiple:

• Small
• Yellow-white
• Discrete retinal/RPE lesions

These changes are far less common than the anterior segment manifestations.

Typical Laterality

Nutritional vitamin A deficiency is a systemic disorder, so ocular findings are usually:

Bilateral

although severity may be asymmetric.

A highly unilateral presentation should prompt consideration of another diagnosis.

How the Diagnosis Is Made

Diagnosis is based on:

1. Compatible ocular findings
2. Nutritional or malabsorption risk
3. Systemic context
4. Serum retinol when useful

Treatment should not be delayed in severe clinical xerophthalmia while waiting for laboratory confirmation.

Serum Retinol – Important Modern Correction

Older reference ranges are sometimes reported incorrectly.

Vitamin A status is generally assessed using:

Serum retinol concentration.

A level below approximately:

0.70 µmol/L

supports vitamin A deficiency.

More severe deficiency is often considered around:

<0.35 µmol/L.

Why Serum Retinol Is Imperfect

Serum retinol can fall during:

• Acute infection
• Systemic inflammation
• Protein deficiency

because RBP behaves as a negative acute-phase reactant.

Therefore serum retinol must be interpreted alongside:

• Nutritional history
• CRP/inflammatory status
• Clinical findings

Other Laboratory Tests

Depending on the clinical context, evaluation may include:

• CBC
• Albumin
• Liver function
• Zinc
• Other fat-soluble vitamins
• Tests for malabsorption

RBP may sometimes serve as a surrogate marker but is not required routinely.

Conjunctival Impression Cytology

Impression cytology can demonstrate:

• Loss of goblet cells
• Squamous metaplasia
• Keratinization

It is primarily useful for:

• Research
• Population studies
• Selected diagnostic uncertainty

rather than routine management of obvious xerophthalmia.

Schirmer Testing Is Not the Main Diagnostic Test

Older descriptions emphasized Schirmer testing.

However, xerophthalmia is not simply ordinary aqueous-deficient dry eye.

The defining problem is:

Vitamin A–dependent epithelial failure and keratinization.

Schirmer testing may describe tear production but does not establish the diagnosis.

Tear Break-Up Time

TBUT may be abnormal because the ocular surface and mucin layer are disrupted.

Again, this is supportive rather than diagnostic.

Modern diagnosis centers on:

Clinical xerophthalmic signs and systemic vitamin A status.

Important Diagnostic Alternatives

Consider other causes of severe dry or keratinized ocular surface disease, including:

• Sjögren disease
• Stevens–Johnson syndrome
• Toxic epidermal necrolysis
• Ocular mucous membrane pemphigoid
• Chemical injury
• Severe exposure keratopathy
• Neurotrophic keratopathy
• Limbal stem-cell deficiency
• Severe medication toxicity

Distinguishing Xerophthalmia From Ordinary Dry Eye

Typical dry-eye disease may cause:

• Burning
• Fluctuating vision
• Punctate staining

but does not ordinarily produce the classic progression of:

Night blindness → Bitot spots → corneal xerosis → keratomalacia.

Systemic nutritional clues are crucial.

Immediate Treatment Principle

Once xerophthalmia from VAD is suspected:

Systemic vitamin A replacement should be given urgently.

Topical lubrication alone is inadequate.

The goal is to restore vitamin A rapidly before irreversible corneal destruction develops.

Standard WHO-Style Vitamin A Treatment

For children ≥12 months and adults, a commonly used regimen is:

200,000 IU vitamin A orally immediately, repeated the next day, and again after approximately 2 weeks.

Age-adjusted pediatric dosing is used for younger children:

• 6–11 months: 100,000 IU per dose
• <6 months: 50,000 IU per dose

Exact dosing should follow current local/WHO guidance.

Important Correction to Older Two-Dose Regimens

Older texts often listed only:

• Day 1
• Day 2

Modern treatment protocols typically include a:

Third dose approximately 2 weeks later

to replenish hepatic stores and reduce relapse.

When Oral Absorption Is Unreliable

If there is:

• Severe malabsorption
• Persistent vomiting
• Inability to take oral medication

parenteral vitamin A may be considered under specialist guidance.

The exact preparation and dosing depend on:

• Available formulation
• Age
• Systemic condition

Pregnancy Considerations

High-dose vitamin A supplementation requires special caution in pregnancy because excessive preformed vitamin A can be:

Teratogenic.

Pregnant patients with suspected deficiency require:

• Obstetric involvement
• Nutritional assessment
• Guideline-based replacement

Routine megadose therapy should not be improvised.

Ocular Surface Support

Adjunctive treatment may include:

• Preservative-free artificial tears
• Lubricating ointment
• Moisture protection

These help protect the epithelium while systemic deficiency is corrected.

Corneal Epithelial Defect or Ulceration

When epithelial breakdown is present:

• Intensive lubrication
• Close ophthalmic follow-up
• Topical antimicrobial prophylaxis or treatment when appropriate
• Cycloplegia for discomfort in selected cases

may be required.

Secondary microbial infection must be actively excluded.

Why Punctal Plugs Are Not Central Therapy

Older dry-eye approaches sometimes suggested punctal occlusion.

In xerophthalmia, however, the fundamental problem is:

Systemic epithelial vitamin A deficiency, not simply inadequate aqueous retention.

Punctal plugs do not correct the underlying disease and are rarely a priority during active severe xerophthalmia.

Topical Retinoic Acid – Modern Position

Topical retinoic acid has been investigated historically.

It is:

Not routine modern treatment

because:

• Systemic vitamin A replacement is the definitive therapy
• Topical formulations may irritate the surface
• Evidence for clinically meaningful additional benefit is limited

Keratomalacia Management

Keratomalacia requires:

Immediate systemic vitamin A replacement plus intensive corneal management.

Treatment may include:

• Broad-spectrum topical antibiotics if ulceration is present
• Intensive lubrication
• Protection from exposure
• Management of perforation
• Correction of severe malnutrition

These patients often require hospital-level multidisciplinary care.

Why Nutritional Rehabilitation Is Essential

Vitamin A deficiency often coexists with:

• Protein-energy malnutrition
• Zinc deficiency
• Other micronutrient deficiencies
• Infection
• Diarrheal disease

Giving vitamin A without correcting the underlying nutritional disorder can lead to:

Incomplete recovery or recurrence.

Treating the Cause of Malabsorption

In adults from well-nourished settings, severe VAD should trigger evaluation for:

• Bariatric surgery
• Pancreatic insufficiency
• Cholestasis
• Celiac disease
• Crohn disease
• Cystic fibrosis
• Chronic liver disease

Management must address the cause, not merely replace the vitamin.

Corneal Surgery

Surgery has little role during active keratomalacia because tissue may be:

• Necrotic
• Inflamed
• Poorly healing

Emergency tectonic surgery may occasionally be required for perforation.

Once:

• Nutrition is restored
• Surface disease is stable
• Inflammation has resolved

a visually significant corneal scar may potentially be treated with:

• Keratoplasty

but prognosis depends on ocular-surface health.

Why Corneal Transplantation Can Be Difficult

Graft prognosis is poorer when there is:

• Persistent surface keratinization
• Severe dry eye
• Vascularization
• Active malnutrition
• Limbal stem-cell dysfunction

Systemic and surface stabilization should precede elective transplantation.

Visual Recovery

Early disease often improves dramatically after treatment.

Night Blindness

May improve within:

Days

Conjunctival and Early Corneal Xerosis

Can improve over:

Days to weeks

Corneal Scarring

Once established, scar-related visual loss is:

Permanent unless surgically rehabilitated.

Prevention at Population Level

Public-health prevention includes:

• Dietary diversification
• Breastfeeding
• Food fortification
• Vitamin A supplementation programs in high-risk populations
• Measles vaccination
• Control of diarrheal disease
• Improved food security

These interventions reduce both ocular disease and childhood mortality.

Dietary Prevention

Useful vitamin A sources include:

Animal Sources

• Liver
• Eggs
• Dairy products
• Fish

Plant Sources Rich in Provitamin A

• Sweet potato
• Carrot
• Pumpkin
• Spinach
• Other dark-green leafy vegetables
• Orange/yellow fruits

Adding dietary fat improves absorption of carotenoids.

Why Excess Supplementation Is Not Harmless

Vitamin A is fat-soluble and can accumulate.

Chronic excess may cause:

• Hepatotoxicity
• Bone abnormalities
• Intracranial hypertension
• Teratogenicity

Therefore long-term high-dose supplementation should follow:

Established clinical or public-health guidance.

Major Ocular Complications

Untreated severe VAD may lead to:

• Corneal ulceration
• Keratomalacia
• Secondary microbial keratitis
• Corneal perforation
• Dense corneal scar
• Phthisis
• Permanent blindness

In children, persistent unilateral or asymmetric opacity can also produce:

Amblyopia.

Expected Prognosis

Prognosis is excellent when deficiency is recognized:

Before destructive corneal disease develops.

Night blindness and early epithelial abnormalities are highly reversible.

Prognosis becomes much worse once there is:

• Deep stromal melting
• Perforation
• Dense central scarring
• Secondary infection

High-Yield Takeaways

• Xerophthalmia is the ocular manifestation of vitamin A deficiency and ranges from night blindness to keratomalacia and blindness.
• The earliest classic symptom is night blindness because vitamin A is required for rhodopsin regeneration in rod photoreceptors.
• Vitamin A also maintains conjunctival and corneal epithelial differentiation and goblet-cell function.
• The WHO sequence is XN → X1A → X1B → X2 → X3A/X3B → XS, representing progressively more severe disease.
• Bitot spots are foamy white keratinized plaques, usually on the temporal bulbar conjunctiva.
• Keratomalacia is a medical and ophthalmic emergency because corneal melting and perforation can progress rapidly.
• Important risk factors include malnutrition, malabsorption, bariatric surgery, liver/pancreatic disease, severe dietary restriction, and childhood measles.
• Serum retinol <0.70 µmol/L supports deficiency, but levels can be depressed by systemic inflammation and protein deficiency.
• Schirmer testing is not the key diagnostic test; xerophthalmia is fundamentally a nutritional epithelial disease rather than ordinary dry eye.
• Treatment requires urgent systemic vitamin A, not lubrication alone.
• A commonly used WHO regimen for patients ≥12 months is 200,000 IU orally immediately, the next day, and again approximately 2 weeks later, with lower age-adjusted doses for younger infants.
• Severe malabsorption may require parenteral replacement.
• Pregnancy requires specialist-guided dosing because excessive preformed vitamin A can be teratogenic.
• Topical retinoic acid and punctal plugs are not routine primary treatments for xerophthalmia.
• Advanced corneal disease requires aggressive surface protection and treatment of secondary infection while the systemic deficiency is corrected.
• Nutritional rehabilitation must also address protein deficiency, zinc deficiency, infection, and the underlying cause of malabsorption.
• Early disease can reverse rapidly, but established corneal scarring produces permanent visual loss.
• Population prevention relies on dietary diversification, food fortification, supplementation programs, measles vaccination, and improved nutrition and sanitation.